Individual treatment heterogeneity in a three period two treatment cross-over design

MaRDI QIDQ2863750zbMATH OpenFDO

Authors Edwin A. Ndum, Jeffrey M. Albert, Gary L. Gadbury

Publication date 3 December 2013

Published in JP Journal of Biostatistics (Search for Journal in Brave)

Full work available at URL http://www.pphmj.com/abstract/7553.htm

zbMATH Keywords

causal inferenceclinical trialscounterfactualpotential outcomessubject-treatment interactions

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Recommendations

• Individual treatment effects in randomized trials with binary outcomes.
• Cross-over designs for two treatments and correlated errors
• DESIGN AND ANALYSIS ISSUES FOR CROSSOVER DESIGNS IN PHASE I CLINICAL STUDIES
• On Testing of Individual Bioequivalence
• scientific article; zbMATH DE number 472983

Cited in

(2)

• Efficient principally stratified treatment effect estimation in crossover studies with absorbent binary endpoints
• Individual treatment effects in randomized trials with binary outcomes.

This page was built for publication: Individual treatment heterogeneity in a three period two treatment cross-over design

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2863750)